v3.25.2
Condensed Consolidated Statement of Stockholders' Equity/(Deficit) (Unaudited) - USD ($)
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2023 $ 26 $ 200 $ 51,555,427 $ (47,481,836) $ 4,073,817
Balance, shares at Dec. 31, 2023 26,133 200,000      
Series A compensation expense 2,478,125 2,478,125
Net loss (7,954,282) (7,954,282)
Issuance of Series D preferred stock through the settlement and conversion of Revenue Interest Purchase note payable $ 133 999,872 1,000,005
Issuance of Series D preferred stock through the settlement and conversion of Revenue Interest Purchase note payable, shares 133,000      
Balance at Jun. 30, 2024 $ 26 $ 333 55,033,424 (55,436,118) (402,335)
Balance, shares at Jun. 30, 2024 26,133 333,000      
Balance at Mar. 31, 2024 $ 26 $ 200 52,689,427 (50,183,114) 2,506,539
Balance, shares at Mar. 31, 2024 26,133 200,000      
Series A compensation expense 1,344,125   1,344,125
Net loss (5,253,004) (5,253,004)
Issuance of Series D preferred stock through the settlement and conversion of Revenue Interest Purchase note payable $ 133 999,872 1,000,005
Issuance of Series D preferred stock through the settlement and conversion of Revenue Interest Purchase note payable, shares 133,000      
Balance at Jun. 30, 2024 $ 26 $ 333 55,033,424 (55,436,118) (402,335)
Balance, shares at Jun. 30, 2024 26,133 333,000      
Balance at Dec. 31, 2024 $ 77 $ 398 57,453,843 (65,086,200) (7,631,882)
Balance, shares at Dec. 31, 2024 76,516 398,256      
Series A compensation expense 328,126 328,126
Issuance of Common stock in private placement $ 469 2,499,531 2,500,000
Issuance of Common Stock for private placement, shares 468,650      
Conversion of notes payable into Common Stock $ 3,768 18,322,539 18,326,307
Conversion of notes payable into common Stock, shares 3,768,200      
Conversion of Series D Preferred Stock into Common Stock $ 18 $ (207) 189
Conversion of Series D Preferred Stock into Common Stock, shares 17,667 (206,614)      
Offering costs (380,251) (380,251)
Net loss (23,196,999) (23,196,999)
Issuance of Common Stock for liabilities settlement $ 2,453 $ 79 6,731,649 6,734,181
Issuance of Common Stock for liabilities settlement, shares 2,453,928 79,000      
Issuance of Series D Preferred Stock for liabilities settlement $ 50 $ 19 190,352 190,421
Issuance of Series D Preferred Stock for liabilities settlement, shares 50,050 18,736      
Issuance of Common stock in connection with consulting and financing arrangement $ 5 2,201 2,206
Issuance of Common stock in connection with consulting and financing arrangement, shares 4,680      
Effect of reverse stock split round lot shares $ 23 (23)
Effect of reverse stock split round lot shares, shares 23,578      
Balance at Jun. 30, 2025 $ 6,863 $ 289 85,148,156 (88,283,199) (3,127,891)
Balance, shares at Jun. 30, 2025 6,863,269 289,378      
Balance at Mar. 31, 2025 $ 710 $ 328 62,131,745 (70,145,456) (8,012,673)
Balance, shares at Mar. 31, 2025 709,984 328,658      
Series A compensation expense 164,063 164,063
Issuance of Series D preferred stock and common stock for liabilities settlement $ 2,171 $ 79 4,134,554 4,136,804
Issuance of Series D preferred stock and common stock for liabilities settlement, shares 2,171,648 79,000      
Issuance of Common stock in private placement $ 469 2,499,531 2,500,000
Issuance of Common Stock for private placement, shares 468,650      
Conversion of notes payable into Common Stock $ 3,463 16,598,446 16,601,909
Conversion of notes payable into common Stock, shares 3,462,937      
Conversion of Series D Preferred Stock into Common Stock $ 50 $ (118) 68 0
Conversion of Series D Preferred Stock into Common Stock, shares 50,050 (118,280)      
Offering costs (380,251) (380,251)
Net loss (18,137,743) (18,137,743)
Balance at Jun. 30, 2025 $ 6,863 $ 289 $ 85,148,156 $ (88,283,199) $ (3,127,891)
Balance, shares at Jun. 30, 2025 6,863,269 289,378